Source: Eur Respir J 2012; 39: 1537-1538



Rating:

Share or cite this content

Citations should be made in the following way:
Jones Andrew, Beisty Judith, McKenna Diane, Clough Debbie, Webb Kevin, Morris Julie, Keevil Brian. Monitoring of tobramycin levels in patients with cystic fibrosis by finger-prick sampling. Eur Respir J 2012; 39: 1537-1538

Member's Comments

No comment yet.

Related content which might interest you: Lung function parameters influence serum concentration after antibiotic inhalation in patients with cystic fibrosis Source: Eur Respir J 2001; 18: Suppl. 33, 537s Year: 2001 Once-daily tobramycin in the treatment of adult patients with cystic fibrosis Source: Eur Respir J 2002; 19: 303-309 Year: 2002 Long-term administration of aerosolised tobramycin in patients with cystic fibrosis Source: Eur Respir J 2005; 26: Suppl. 49, 619s Year: 2005 Control of the inhalation technique in cystic fibrosis patients Source: Eur Respir J 2006; 28: Suppl. 50, 262s Year: 2006 Assessment of regional resistance distribution using computational fluid dynamics in cystic fibrosis patients Source: Annual Congress 2007 - Cystic fibrosis lung disease: what do we measure? What do we know? Year: 2007 Home intravenous antibiotic treatments in cystic fibrosis adult patients Source: Eur Respir J 2002; 20: Suppl. 38, 158s Year: 2002 Longitudinal course of clinically measured lung clearance index in children with cystic fibrosis Source: Virtual Congress 2020 – New frontiers in cystic fibrosis imaging and lung physiology Year: 2020 Urinary excretion reflects lung deposition of aminoglycoside aerosols in cystic fibrosis Source: Eur Respir J 2001; 18: 316-322 Year: 2001 The characteristics of the minimum inhibitory concentration of antibiotics on pulmonary infections in patients with cystic fibrosis Source: International Congress 2015 – Novel strategies for the management of asthma, COPD and airway infections Year: 2015 Blood gas analysis to predict survival in patients with cystic fibrosis Source: Virtual Congress 2020 – Clinical monitoring and new therapies for cystic fibrosis Year: 2020 Serum bactericidal activity in non cystic fibrosis bronchiectasis in patients with pseudomonas aeruginosa colonisation Source: Annual Congress 2011 - Pseudomonas aeruginosa infection and non-cystic fibrosis bronchiectasis Year: 2011 Adherence with inhaled colistimethate sodium during a 6 month study in patients with non-cystic fibrosis bronchiectasis Source: Annual Congress 2013 –Treating bronchiectasis in respiratory patients Year: 2013 Improvement in pulmonary function after IV antibiotic treatment in cystic fibrosis patients Source: Eur Respir J 2002; 20: Suppl. 38, 342s Year: 2002 Elevated glucose concentrations in respiratory droplets of cystic fibrosis patients Source: Eur Respir J 2002; 20: Suppl. 38, 527s Year: 2002 Lung clearance index in cystic fibrosis subjects treated for pulmonary exacerbations Source: Eur Respir J 2015; 46: 1055-1064 Year: 2015 Sputum glucose as a marker of disease severity in adult patients with cystic fibrosis Source: International Congress 2018 – Cystic fibrosis in adults: current research Year: 2018 Comparison of induced sputum samples, versus BAL samples in detection of the microbial load among children with cystic fibrosis Source: Annual Congress 2009 - Cystic fibrosis: understanding a complex disease Year: 2009 Serum lipid concentrations and malnutrition in adult cystic fibrosis patients Source: Eur Respir J 2006; 28: Suppl. 50, 58s Year: 2006 Cystic fibrosis patients have different microbiological colonization comparing to other bronchiectasis Source: Annual Congress 2010 - New aspects of cystic fibrosis Year: 2010 Evaluation of inhaled dry powder tobramycin free base in non-cystic fibrosis bronchiectasis patients Source: International Congress 2016 – Clinical and microbiological aspects of bronchiectasis and non-tuberculous mycobacterium (NTM) infections Year: 2016